{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:08:29Z","timestamp":1788883709467,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cytogfr.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:27:38Z","timestamp":1787034458000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TRAF3IP2 (Act1\/CIKS) variants: A domain to phenotype framework and therapeutic implications"],"prefix":"10.1016","volume":"91","author":[{"given":"Eckhard U.","family":"Alt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-8150","authenticated-orcid":false,"given":"Reza","family":"Izadpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2026.08.003_bib1","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1073\/pnas.160265197","article-title":"Act1, an NF-kappa B-activating protein","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib2","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1073\/pnas.190245697","article-title":"CIKS, a connection to Ikappa B kinase and stress-activated protein kinase","volume":"97","author":"Leonardi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-1119(00)00231-6","article-title":"Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia","volume":"252","author":"Morelli","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","article-title":"Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis","volume":"42","author":"Huffmeier","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1439","article-title":"The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease","volume":"8","author":"Qian","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib7","doi-asserted-by":"crossref","first-page":"35603","DOI":"10.1074\/jbc.C600256200","article-title":"Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor","volume":"281","author":"Chang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib8","doi-asserted-by":"crossref","first-page":"ra63","DOI":"10.1126\/scisignal.2000382","article-title":"Act1, a U-box E3 ubiquitin ligase for IL-17 signaling","volume":"2","author":"Liu","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.immuni.2004.09.001","article-title":"Act1, a negative regulator in CD40- and BAFF-mediated B cell survival","volume":"21","author":"Qian","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2479","article-title":"The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90","volume":"14","author":"Wang","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-019-00664-x","article-title":"Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2","volume":"39","author":"Bhattad","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cge.13767","article-title":"A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans","volume":"98","author":"Nemer","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00251-013-0717-6","article-title":"TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development","volume":"65","author":"Perricone","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.crohns.2012.02.020","article-title":"TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease","volume":"7","author":"Ciccacci","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22402","article-title":"Plasma CXCL1 levels and TRAF3IP2 variants in patients with myocardial infarction","volume":"32","author":"Pordel","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib18","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/jac\/dky180","article-title":"A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome\/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine","volume":"73","author":"Ciccacci","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib19","doi-asserted-by":"crossref","first-page":"29772","DOI":"10.18632\/oncotarget.25710","article-title":"TRAF3IP2, a novel therapeutic target in glioblastoma multiforme","volume":"9","author":"Alt","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib20","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1038\/s41598-020-64781-z","article-title":"Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer","volume":"10","author":"Alt","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.893820","article-title":"Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma","volume":"12","author":"Izadpanah","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-29057-4","article-title":"Targeting TRAF3IP2 disrupts cellular energetics through inhibition of NAMPT in triple negative breast cancer","author":"Willingham","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11481-025-10252-z","article-title":"Inhibition of TRAF3IP2 Modulates NAMPT and NAD Metabolism in Glioblastoma","volume":"20","author":"Willingham","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib24","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.62347\/UJZK5358","article-title":"Downregulated TRAF3IP2-AS1 promotes hepatocellular carcinoma progression through the miR-374a-5p\/SEL1L1\/RPL6 axis to enhance DNA damage repair","volume":"17","author":"Wang","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib25","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.2001223","article-title":"Identification of a Long Noncoding RNA TRAF3IP2-AS1 as Key Regulator of IL-17 Signaling through the SRSF10-IRF1-Act1 Axis in Autoimmune Diseases","volume":"206","author":"He","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s10875-021-01026-2","article-title":"A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis","volume":"41","author":"Marujo","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib27","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/pai.13603","article-title":"Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant","volume":"32","author":"Blanco Lobo","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/ar4071","article-title":"New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis","volume":"14","author":"Doyle","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib29","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.4049\/jimmunol.1202922","article-title":"Crystal structure of IL-17 receptor B SEFIR domain","volume":"190","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12030456","article-title":"Of Mycelium and Men: Inherent Human Susceptibility to Fungal Diseases","volume":"12","author":"Vinh","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","article-title":"Human inborn errors of immunity underlying superficial or invasive candidiasis","volume":"139","author":"Puel","year":"2020","journal-title":"Hum. Genet."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2016.05.029","article-title":"TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-\/-) mice","volume":"252","author":"Sakamuri","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib34","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1074\/jbc.M116.764522","article-title":"Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia\/Reperfusion-induced Myocardial Injury and Adverse Remodeling","volume":"292","author":"Erikson","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.120.15262","article-title":"TRAF3IP2 (TRAF3 Interacting Protein 2) mediates obesity-associated vascular insulin resistance and dysfunction in male mice","volume":"76","author":"Grunewald","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s43682-022-00014-w","article-title":"A longitudinal epigenome-wide association study of preeclamptic and normotensive pregnancy","volume":"3","author":"Liu","year":"2023","journal-title":"Epigenetics Commun."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-013-1407-9","article-title":"Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk","volume":"306","author":"Debniak","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2020.12.629","article-title":"Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency","volume":"148","author":"Shafer","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050404","article-title":"Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients","volume":"8","author":"Park","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/gepi.20421","article-title":"Gene-environment interaction tests for dichotomous traits in trios and sibships","volume":"33","author":"Hoffmann","year":"2009","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/db11-1263","article-title":"Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression","volume":"61","author":"Bergholdt","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34815-8","article-title":"Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics","volume":"8","author":"John","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/ar3807","article-title":"Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization","volume":"14","author":"Bohm","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169956","article-title":"Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis","volume":"12","author":"Conigliaro","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.cytogfr.2026.08.003_bib46","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.4049\/jimmunol.1400715","article-title":"The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling","volume":"193","author":"Wu","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib47","article-title":"Genetics of psoriasis and pharmacogenetics of biological drugs","volume":"2013","author":"Prieto-Perez","year":"2013","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.humimm.2016.10.018","article-title":"Psoriasis risk SNPs and their association with HIV-1 control","volume":"78","author":"Nititham","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/bjd.12442","article-title":"Gene-gene interactions between HLA-C, ERAP1, TNFAIP3 and TRAF3IP2 and the risk of psoriasis in the Chinese Han population","volume":"169","author":"Yin","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cytogfr.2026.08.003_bib51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jid.2018.11.021","article-title":"Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype","volume":"139","author":"Lambert","year":"2019","journal-title":"J. Invest. Dermatol."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:30:55Z","timestamp":1788881455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S1359610126000614"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.08.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRAF3IP2 (Act1\/CIKS) variants: A domain to phenotype framework and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}